Partially Unified Multiple Property Recursive Partitioning (PUMP-RP) Analyses of Cyclooxygenase (COX) Inhibitors

We have carried out partially unified multiple property recursive partitioning (PUMP-RP) analyses on a database of cyclooxygenase (COX) inhibitors, using CART methods implemented in Cerius(2). Three sets of physicochemical descriptors (ISIS public keys, DAYLIGHT Fingerprints, and Cerius(2)) were computed for the database molecules which were divided into two groups, assigned as training (89%) and test (11%-selected using diversity analyses tools in Cerius(2)) sets. The descriptors which led to the discrimination of active and selective COX-2 inhibitors included ISIS Key #59 (Snot%A%A), Balaban electrotopological index JY, partition coefficient AlogP, and Jurs surface area descriptors (FNSA, FPSA, and PPSA). A strong correlation is obtained between the predicted and experimental COX-2 inhibitory activity and a moderate correlation for selectivity of the COX-2 inhibitors, both in the training and test sets. Application of the RP trees to a validation set of Merck cyclooxygenase inhibitors shows good consistency with the COX-1 and COX-2 activity data, albeit moderate consistency with the selectivity data. Compared to the independent RP models (obtained by considering each activity separately), the PUMP-RP decision trees provide easier identification and interpretation of those descriptors that are common to both COX-1 and COX-2 activities. Similarly, they are easier to distinguish the descriptors that discriminate the two activities. The study represents a preliminary validation of the PUMP-RP method described in the previous article of this issue.

[1]  D. Riendeau,et al.  In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663). , 2001, Bioorganic & medicinal chemistry letters.

[2]  C. Koboldt,et al.  SELECTIVE CYCLOOXYGENASE INHIBITORS : NOVEL 4-SPIRO 1,2-DIARYLCYCLOPENTENES ARE POTENT AND ORALLY ACTIVE COX-2 INHIBITORS , 1995 .

[3]  E A Kowaluk,et al.  Emerging molecular approaches to pain therapy. , 1999, Journal of medicinal chemistry.

[4]  R. S. Rogers,et al.  3,4-diarylthiophenes are selective COX-2 inhibitors , 1995 .

[5]  M. Percival,et al.  Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. , 1995, The Biochemical journal.

[6]  C. Koboldt,et al.  1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2. , 1997, Journal of medicinal chemistry.

[7]  C. Koboldt,et al.  Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. , 1994, Journal of medicinal chemistry.

[8]  R Gordon,et al.  2,3-Diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors. , 1999, Journal of medicinal chemistry.

[9]  C. Koboldt,et al.  Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. , 1996, Journal of medicinal chemistry.

[10]  E. Knaus,et al.  Design and synthesis of celecoxib and rofecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of sulfonamide and methylsulfonyl pharmacophores by an azido bioisostere. , 2001, Journal of medicinal chemistry.

[11]  C. Koboldt,et al.  1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents. , 1997, Journal of medicinal chemistry.

[12]  Thomas P. Stockfisch,et al.  Partially Unified Multiple Property Recursive Partitioning (PUMP-RP): A New Method for Predicting and Understanding Drug Selectivity , 2003, J. Chem. Inf. Comput. Sci..

[13]  C. Koboldt,et al.  Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors. , 1999, Bioorganic & medicinal chemistry letters.

[14]  C. Koboldt,et al.  Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationships. , 1996, Journal of medicinal chemistry.

[15]  Jacob Cohen.  A Coefficient of Agreement for Nominal Scales , 1960 .

[16]  Hong Li,et al.  Novel algorithms for the optimization of molecular diversity of combinatorial libraries11Color Plates for this article are on pages 533–536. , 2000 .

[17]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[18]  K. Seibert,et al.  Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. FitzGerald,et al.  The coxibs, selective inhibitors of cyclooxygenase-2. , 2001, The New England journal of medicine.

[20]  R Gordon,et al.  Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. , 2001, The Journal of pharmacology and experimental therapeutics.

[21]  C. Koboldt,et al.  Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents. , 2000, Journal of medicinal chemistry.

[22]  C. Bayly,et al.  Structure-based design of COX-2 selectivity into flurbiprofen. , 1999, Bioorganic & medicinal chemistry letters.

[23]  J. Talley,et al.  Selective inhibitors of cyclooxygenase-2 (COX-2). , 1999, Progress in medicinal chemistry.

[24]  Robert D. Brown,et al.  Combinatorial library design for diversity, cost efficiency, and drug-like character. , 2000, Journal of molecular graphics & modelling.

[25]  Marvin Waldman,et al.  Optimization and visualization of molecular diversity of combinatorial libraries , 1996, Molecular Diversity.

[26]  C. Koboldt,et al.  1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. , 1995, Journal of medicinal chemistry.

[27]  J. Smith,et al.  Aspirin selectively inhibits prostaglandin production in human platelets. , 1971, Nature: New biology.

[28]  4,5‐Diaryloxazole inhibitors of cyclooxygenase‐2 (COX‐2) , 1999, Medicinal research reviews.

[29]  C. Koboldt,et al.  Diaryl indenes and benzofurans: Novel classes of potent and selective cyclooxygenase-2 inhibitors , 1995 .

[30]  R. S. Rogers,et al.  Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). , 1997, Journal of medicinal chemistry.